Results 251 to 260 of about 168,641 (363)

Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA‐HF trial

open access: yesESC Heart Failure, EarlyView.
Graphical presentation of the study design, main results and conclusion. Abbreviations: Y/O = year old; HFpEF = heart failure with preserved ejection fraction; Kg = kilograms; NYHA = New York Heart Association; ACE = angiotensin‐converting enzyme; ARB = angiotensin receptor blockers; ARNI = angiotensin receptor‐neprilysin inhibitor; SGLT2i = sodium ...
Amit Gruber   +14 more
wiley   +1 more source

Developmental and Molecular Effects of C-Type Natriuretic Peptide Supplementation in In Vitro Culture of Bovine Embryos. [PDF]

open access: yesInt J Mol Sci
Costa CB   +8 more
europepmc   +1 more source

Sex-specific mortality prediction by pro-C-type natriuretic peptide measurement in a prospective cohort of patients with ST-elevation myocardial infarction. [PDF]

open access: yesBMJ Open, 2021
Mark PD   +9 more
europepmc   +1 more source

Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung   +8 more
wiley   +1 more source

B‐type natriuretic peptide and C‐terminal‐pro‐endothelin‐1 for the prediction of severely impaired peak oxygen consumption [PDF]

open access: bronze, 2009
Micha T. Maeder   +12 more
openalex   +1 more source

Immuno‐haemostatic dysregulation in heart failure with preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex condition with partially unclear pathophysiology, in which systemic inflammation is a central contributor to changes in cardiac structure and function. The contribution of non‐traditional immune effectors—such as platelets and coagulation—remains underexplored in HFpEF ...
Giorgia D'Italia   +13 more
wiley   +1 more source

Auto/Paracrine C-Type Natriuretic Peptide/Cyclic GMP Signaling Prevents Endothelial Dysfunction. [PDF]

open access: yesInt J Mol Sci
Werner F   +12 more
europepmc   +1 more source

C-Type Natriuretic Peptide Forms in Pregnancy: Maternal Plasma Profiles during Ovine Gestation Correlate with Placental and Fetal Maturation [PDF]

open access: bronze, 2009
B. A. McNeill   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy